[Purification and anti-cancer activity of ricin]

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005 May;34(3):217-9. doi: 10.3785/j.issn.1008-9292.2005.03.005.
[Article in Chinese]

Abstract

Objective: To extract and purify ricin from castor beans and to evaluate its anti-cancer activity.

Methods: Ricin was purified from castor beans according the modified method of Nicolson and Blaustin. The lectins were extracted in 0.01 mol/L phosphate buffered saline and isolated in the 40% to 80% fraction of ammonium sulfate precipitation. The dialyzed fractionated preparation was applied with a Sepharose 4B column. The lectins were eluted with a linear lactose gradient (0.01 mol/L approximately 0.5 mol/L). Ricin was separated from the ricinus agglutinin by gel filtration on a Sephadex G-100. MTT was applied to analyze the cytotoxicity with different dosage of ricin in different cancer cell lines.

Results: There was no difference between the killing effect of normal cells and that of colon cancer cells by using the high dosage of ricin (5 x 10(-8) mol/L approximately 5 x 10(-10) mol/L). However, the cytotoxicity was significant different in those cells with the low dosage of ricin (5 x 10(-11) mol/L approximately 5 x 10(-13) mol/L). Meanwhile ricin had the similar cytotoxicity to leukemia cell K562 and colon cancer cell SW480.

Conclusion: Ricin is able to kill tumor cells selectively at low concentration, but the selectivity does not appear at high concentrations.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Cell Line, Tumor
  • Colorectal Neoplasms / pathology
  • Dose-Response Relationship, Drug
  • Humans
  • K562 Cells
  • Male
  • Mice
  • Rats
  • Rats, Sprague-Dawley
  • Ricin / isolation & purification*
  • Ricin / pharmacology*
  • T-Lymphocytes, Cytotoxic

Substances

  • Antineoplastic Agents, Phytogenic
  • Ricin